Frontier Bio
About:
The Future of Engineered Tissue
Website: https://www.frontierbio.com
Twitter/X: Frontier_Bio
Top Investors: National Science Foundation, Artesian VC, Alchemist Accelerator, Brinc, SkyDeck Berkeley
Description:
Frontier Bio is developing advanced tissue engineering and 3D bioprinting techniques for addressing unmet clinical needs.
Total Funding Amount:
$2.88M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Hayward, California, United States
Founded Date:
2018-01-01
Contact Email:
hello(AT)frontierbio.com
Founders:
Eric Bennett
Number of Employees:
11-50
Last Funding Date:
2022-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai